306 related articles for article (PubMed ID: 17392389)
1. Glycosylation of sputum mucins is altered in cystic fibrosis patients.
Schulz BL; Sloane AJ; Robinson LJ; Prasad SS; Lindner RA; Robinson M; Bye PT; Nielson DW; Harry JL; Packer NH; Karlsson NG
Glycobiology; 2007 Jul; 17(7):698-712. PubMed ID: 17392389
[TBL] [Abstract][Full Text] [Related]
2. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.
Henke MO; John G; Germann M; Lindemann H; Rubin BK
Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563
[TBL] [Abstract][Full Text] [Related]
3. Identification of MUC5B, MUC5AC and small amounts of MUC2 mucins in cystic fibrosis airway secretions.
Davies JR; Svitacheva N; Lannefors L; Kornfält R; Carlstedt I
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):321-30. PubMed ID: 10567212
[TBL] [Abstract][Full Text] [Related]
4. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.
Henke MO; Renner A; Huber RM; Seeds MC; Rubin BK
Am J Respir Cell Mol Biol; 2004 Jul; 31(1):86-91. PubMed ID: 14988081
[TBL] [Abstract][Full Text] [Related]
5. Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.
Schulz BL; Sloane AJ; Robinson LJ; Sebastian LT; Glanville AR; Song Y; Verkman AS; Harry JL; Packer NH; Karlsson NG
Biochem J; 2005 May; 387(Pt 3):911-9. PubMed ID: 15563276
[TBL] [Abstract][Full Text] [Related]
6. Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7.
Shori DK; Genter T; Hansen J; Koch C; Wyatt H; Kariyawasam HH; Knight RA; Hodson ME; Kalogeridis A; Tsanakas I
Pflugers Arch; 2001; 443 Suppl 1():S55-61. PubMed ID: 11845304
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
[TBL] [Abstract][Full Text] [Related]
8. Altered O-glycosylation and sulfation of airway mucins associated with cystic fibrosis.
Xia B; Royall JA; Damera G; Sachdev GP; Cummings RD
Glycobiology; 2005 Aug; 15(8):747-75. PubMed ID: 15994837
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and lipid-derived inflammatory mediators during acute exacerbations of cystic fibrosis.
Reid DW; Misso N; Aggarwal S; Thompson PJ; Walters EH
Respirology; 2007 Jan; 12(1):63-9. PubMed ID: 17207027
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype.
Venkatakrishnan V; Thaysen-Andersen M; Chen SC; Nevalainen H; Packer NH
Glycobiology; 2015 Jan; 25(1):88-100. PubMed ID: 25190359
[TBL] [Abstract][Full Text] [Related]
11. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
12. Biochemical properties of tracheobronchial mucins from cystic fibrosis and non-cystic fibrosis individuals.
Rose MC; Brown CF; Jacoby JZ; Lynn WS; Kaufman B
Pediatr Res; 1987 Nov; 22(5):545-51. PubMed ID: 3684381
[TBL] [Abstract][Full Text] [Related]
13. Sulphation of the salivary mucin MG1 (MUC-5B) is not correlated to the degree of its sialylation and is unaffected by cystic fibrosis.
Shori DK; Kariyawasam HH; Knight RA; Hodson ME; Genter T; Hansen J; Koch C; Kalogeridis A
Pflugers Arch; 2001; 443 Suppl 1():S50-4. PubMed ID: 11845303
[TBL] [Abstract][Full Text] [Related]
14. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
[TBL] [Abstract][Full Text] [Related]
15. Mucin genes have different expression patterns in healthy and diseased upper airway mucosa.
Martínez-Antón A; Debolós C; Garrido M; Roca-Ferrer J; Barranco C; Alobid I; Xaubet A; Picado C; Mullol J
Clin Exp Allergy; 2006 Apr; 36(4):448-57. PubMed ID: 16630149
[TBL] [Abstract][Full Text] [Related]
16. Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis.
Horsley A; Rousseau K; Ridley C; Flight W; Jones A; Waigh TA; Thornton DJ
J Cyst Fibros; 2014 May; 13(3):260-6. PubMed ID: 24332705
[TBL] [Abstract][Full Text] [Related]
17. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
18. Reevaluating gel-forming mucins' roles in cystic fibrosis lung disease.
Perez-Vilar J; Boucher RC
Free Radic Biol Med; 2004 Nov; 37(10):1564-77. PubMed ID: 15477008
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.
Kirkham S; Sheehan JK; Knight D; Richardson PS; Thornton DJ
Biochem J; 2002 Feb; 361(Pt 3):537-46. PubMed ID: 11802783
[TBL] [Abstract][Full Text] [Related]
20. Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients.
Khatri IA; Bhaskar KR; Lamont JT; Sajjan SU; Ho CK; Forstner J
Pediatr Res; 2003 Apr; 53(4):619-27. PubMed ID: 12612214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
